Phillips‑Medisize (a Molex company)
Is this your company? Claim this profile
Drug Product
Manufacturing & Lab Equipment
Company Overview
About
Phillips‑Medisize (a Molex company) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:China
Founded:1993
Employees:1,938
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Global
Regulatory Approvals
Drug Approval NLLQF7
FDA · #APR-4VQFF1KR · 2019-07-01
Drug Approval 1G2KRO
PMDA · #APR-NNVTNRVH · 2019-01-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-A2X4CTLD
Issued: 2020-02-10
Expires: 2025-08-18
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-CT9BVUNW
Issued: 2020-09-23
Expires: 2025-04-19
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-QN0E5NBX
Issued: 2020-10-14
Expires: 2025-09-18
Health Canada GMP
Health Canada
Cert #: CERT-29XBYPAW
Issued: 2020-04-26
Expires: 2025-05-07
Loading CDMO intelligence...
Key facts about Phillips‑Medisize (a Molex company)
- Phillips‑Medisize (a Molex company) is headquartered in China.
- Phillips‑Medisize (a Molex company) was founded in 1993.
- Phillips‑Medisize (a Molex company) has 1,938 employees.
- Phillips‑Medisize (a Molex company)'s capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Phillips‑Medisize (a Molex company)
Directory pages this company appears in, each with the full list of matching manufacturers.